Definition: The essential feature is recurrent obsessional thoughts or compulsive acts. Obsessional thoughts are ideas, images, or impulses that enter the patient's mind again and again in a stereotyped form. They are almost invariably distressing and the patient often tries, unsuccessfully, to resist them. They are, however, recognized as his or her own thoughts, even though they are involuntary and often repugnant. Compulsive acts or rituals are stereotyped behaviours that are repeated again and again. They are not inherently enjoyable, nor do they result in the completion of inherently useful tasks. Their function is to prevent some objectively un ...[+++]likely event, often involving harm to or caused by the patient, which he or she fears might otherwise occur. Usually, this behaviour is recognized by the patient as pointless or ineffectual and repeated attempts are made to resist. Anxiety is almost invariably present. If compulsive acts are resisted the anxiety gets worse. | anankastic neurosis obsessive-compulsive neurosis

agricultural equipment test engineer | test engineer

flight test performance engineer | flight testing engineer | flight test engineer | flight test technician

health and safety advisor | occupational health officer | health and safety officer | occupational health nurse

impact test

laboratory test

randomised clinical trial | randomised trial

It is declining by decade. As an example — and this is a published paper in circulation — if you look at trials for stroke prevention, which I would argue is by far the most effective way to deal with a disease of this magnitude, in the 1990s, 24 such trials were conducted.

This is really related to crime prevention, so I'm trying to figure out how we measure success of that particular program as it relates to crime prevention a year from now, two years from now, and down the road.

(a) Support clinical trials on new or improved medical interventions for poverty-related and neglected diseases through partnerships between European and developing countries, in particular sub- Saharan Africa:

Indicator : increase the number of supported clinical trials to at least 150, compared to 88 under EDCTP1, that lead to new products, processes, methodologies, diagnostics, treatments or preventions.